| 000 | 01110 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516211357.0 | ||
| 264 | 0 | _c20141216 | |
| 008 | 201412s 0 0 eng d | ||
| 022 | _a1098-8971 | ||
| 024 | 7 |
_a10.1055/s-0034-1371012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSulkowski, Mark S | |
| 245 | 0 | 0 |
_aInterferon-containing and interferon-free HCV therapy for HIV-infected patients. _h[electronic resource] |
| 260 |
_bSeminars in liver disease _cFeb 2014 |
||
| 300 |
_a72-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 | _aCoinfection |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferons _xadverse effects |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tSeminars in liver disease _gvol. 34 _gno. 1 _gp. 72-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0034-1371012 _zAvailable from publisher's website |
| 999 |
_c23782425 _d23782425 |
||